csirt@kutim:~/threat-intel/cve/CVE-2024-22422

Katalog CVE

CVSS 7.5 · High EPSS 1,0%

Kerentanan Improper Check for Unusual or Exceptional Conditions pada mintplexlabs anythingllm. Skor CVSS 3.1 7.5 (High) menurut NVD.

Deskripsi (NVD)

AnythingLLM is an application that turns any document, resource, or piece of content into context that any LLM can use as references during chatting. In versions prior to commit `08d33cfd8` an unauthenticated API route (file export) can allow attacker to crash the server resulting in a denial of service attack. The “data-export” endpoint is used to export files using the filename parameter as user input. The endpoint takes the user input, filters it to avoid directory traversal attacks, fetches the file from the server, and afterwards deletes it. An attacker can trick the input filter mechanism to point to the current directory, and while attempting to delete it the server will crash as there is no error-handling wrapper around it. Moreover, the endpoint is public and does not require any form of authentication, resulting in an unauthenticated Denial of Service issue, which crashes the instance using a single HTTP packet. This issue has been addressed in commit `08d33cfd8`. Users are advised to upgrade. There are no known workarounds for this vulnerability.

Rincian

Terbit di NVD
19 Januari 2024
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
7.5 (High), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-754: Improper Check for Unusual or Exceptional Conditions
EPSS (30 hari)
1,0% peluang dieksploitasi; lebih tinggi dari 63,2% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
mintplexlabs anythingllm Semua versi sebelum 2024-01-18

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.